News and applications for life science research professionals
Radioactive Nanoparticles Target Cancer Cells
May 22, 2013 11:15 am | News | CommentsCancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop. Now, researchers have found a way to create radioactive nanoparticles that target lymphoma tumor cells wherever they may be in the body.
Researchers Closer to Alzheimer's Prevention, Treatment
May 22, 2013 11:10 am | News | CommentsImagine a pharmaceutical prevention, treatment or even cure for Alzheimer’s disease. It is almost impossible to overstate how monumental a development that would be and how it would answer the prayers of millions. Though science isn’t there yet, a new study offers a tantalizing glimpse of potential solutions.
Pfizer plans offering to pare Zoetis stake
May 22, 2013 10:52 am | by The Associated Press | News | CommentsDrugmaker Pfizer Inc. plans to start selling its remaining stake in the animal health business Zoetis Inc. through a voluntary exchange offer with Pfizer shareholders. Pfizer said Wednesday its shareholders will be able to trade their Pfizer holdings for Zoetis shares at a discount, depending on...
More doctors, hospitals using electronic records
May 22, 2013 10:45 am | by The Associated Press | News | CommentsThe Obama administration says more doctors and hospitals are embracing technology as adoption of computerized medical records reaches a "tipping point" in America. A report Wednesday from Health and Human Services says more than 50 percent of doctors' offices and 4 in 5 hospitals have...
One-step Genetic Engineering Technology Developed
May 22, 2013 10:06 am | News | CommentsA new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting. The method paves the way for more rapid development of designer microbes for drug development, environmental cleanup and other activities.
Life-saving face transplant performed in Poland
May 22, 2013 12:37 am | by The Associated Press | News | CommentsDoctors in Poland say they have performed an urgent total face transplant on a 33-year-old man whose face was torn off in an accident which also crushed his jaws. Doctors at the Oncology Center in Gliwice said the 27-hour operation was performed May 15, just weeks after the accident.
Biogen submits new MS drug for FDA approval
May 21, 2013 3:13 pm | by The Associated Press | News | CommentsSpecialty drugmaker Biogen Idec said Tuesday it submitted a new injectable multiple sclerosis drug to the Food and Drug Administration for U.S. market approval. The drug, called Plegridy, is intended to treat patients with relapsing forms of multiple sclerosis, a disease of the immune system in...
RNA 'Transcriptome' Sequenced in Immune Cells
May 21, 2013 2:22 pm | by Broad Institute of MIT and Harvard | News | CommentsWhen studying any kind of population — people or cells — averaging is a useful, if flawed, form of measurement. According to the US Census Bureau, the average American household size in 2010 was 2.59. Of course, there are no homes with exactly 2.59 people.
Automated Drying or Concentration of Very Large Volumes
May 21, 2013 2:16 pm | Product Releases | CommentsGenevac launched the ROCKET 4D—a fully automated system for automatic drying or concentration of very large volumes (a few to 100 liters) in one operation with no user interaction. The ROCKET 4D uses proprietary vacuum technology to suppress solvent bumping and foaming.
Networked Solution Provides Compliant Storage of ICP-MS Data
May 21, 2013 1:43 pm | Product Releases | CommentsAgilent Technologies announced OpenLAB Data Store for MS, a networked solution for compliant storage of mass spectral data acquired with Agilent’s ICP-MS MassHunter system. The software is designed for medium to small laboratories measuring inorganic impurities in pharmaceutical products and ingredients in accordance with upcoming specifications from the United States Pharmacopoeia.
France: Drugmaker on trial, suspected in deaths
May 21, 2013 1:35 pm | by The Associated Press | News | CommentsThe makers of a diabetes and weight loss drug suspected in the deaths of hundreds of people went on trial Tuesday, facing charges they misled the public about the product's safety. But after years of delays in one of France's biggest recent health scandals, the proceedings could still be pushed...
Vitamin C Kills Drug-resistant TB
May 21, 2013 12:00 pm | by Einstein | News | CommentsResearchers have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design.
Cloud-based Collaboration Suite
May 21, 2013 11:56 am | Product Releases | CommentsAccelrys offers the Accelrys Externalized Collaboration Suite, a software solution designed specifically to address the needs of life sciences organizations engaged in externalized network research.
Salamanders Hold Solution to 'Perfect' Regeneration
May 21, 2013 11:45 am | News | CommentsSalamanders’ immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have found. New research found that when immune cells known as macrophages were systemically removed, salamanders lost their ability to regenerate a limb and instead formed scar tissue.
AcelRx pain treatment meets late-stage study goals
May 21, 2013 11:30 am | by The Associated Press | News | CommentsShares of AcelRx Pharmaceuticals Inc. hit an all-time high price Tuesday, after the specialty drugmaker said its NanoTab pain treatment system met its main goal in late-stage research, and the company is preparing to submit it to regulators for approval. The Redwood City, Calif., company said...
